Anatara Lifesciences Ltd
Anatara Lifesciences Ltd engages in the research, development, and commercialization of evidence-based solutions for gastrointestinal diseases in Australia. The company's products include Gastrointestinal ReProgramming, a multi-component, multi-coated medicine designed to address underlying factors associated with chronic gastrointestinal conditions, such as irritable bowel syndrome and inflammat… Read more
Anatara Lifesciences Ltd (ANR) - Total Liabilities
Latest total liabilities as of June 2025: AU$612.42K AUD
Based on the latest financial reports, Anatara Lifesciences Ltd (ANR) has total liabilities worth AU$612.42K AUD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Anatara Lifesciences Ltd - Total Liabilities Trend (2011–2025)
This chart illustrates how Anatara Lifesciences Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Anatara Lifesciences Ltd Competitors by Total Liabilities
The table below lists competitors of Anatara Lifesciences Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Findev Inc
PINK:TNSGF
|
USA | $563.24K |
|
Zamp S.A.
SA:ZAMP3
|
Brazil | R$2.83 Billion |
|
BURGENLAND HOLDING
BE:BH4
|
Germany | €21.34K |
|
ONEOK (ONK.SG)
STU:ONK
|
Germany | €34.16 Billion |
|
Happy Creek Minerals Ltd
PINK:HPYCF
|
USA | $181.58K |
|
Scryb Inc
PINK:SCYRF
|
USA | $1.88 Million |
Liability Composition Analysis (2011–2025)
This chart breaks down Anatara Lifesciences Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.89 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.53 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Anatara Lifesciences Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Anatara Lifesciences Ltd (2011–2025)
The table below shows the annual total liabilities of Anatara Lifesciences Ltd from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$612.42K | +99.58% |
| 2024-06-30 | AU$306.85K | -37.99% |
| 2023-06-30 | AU$494.83K | +22.68% |
| 2022-06-30 | AU$403.35K | -18.79% |
| 2021-06-30 | AU$496.67K | +1.99% |
| 2020-06-30 | AU$486.96K | +4.33% |
| 2019-06-30 | AU$466.76K | -61.90% |
| 2018-06-30 | AU$1.22 Million | +314.62% |
| 2017-06-30 | AU$295.44K | -33.55% |
| 2016-06-30 | AU$444.62K | +202.51% |
| 2015-06-30 | AU$146.98K | -35.43% |
| 2014-06-30 | AU$227.62K | -35.51% |
| 2013-06-30 | AU$352.96K | +141.75% |
| 2012-06-30 | AU$146.00K | +630.00% |
| 2011-06-30 | AU$20.00K | -- |